Patents by Inventor Eric Markel

Eric Markel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080042655
    Abstract: The present invention is directed to various methods and systems for detecting at least one impurity in a bulk fluid. In certain embodiments, the methods are performed in conjunction with a polymerization reactor system such as a gas-phase reactor system.
    Type: Application
    Filed: June 25, 2007
    Publication date: February 21, 2008
    Applicant: UNIVATION TECHNOLOGIES, LLC
    Inventors: Eric Markel, Robert Hagerty, Michael Muhle
  • Publication number: 20080045663
    Abstract: A process for the production of an ethylene alpha-olefin copolymer is disclosed, the process including polymerizing ethylene and at least one alpha-olefin by contacting the ethylene and the at least one alpha-olefin with a metallocene catalyst in at least one gas phase reactor at a reactor pressure of from 0.7 to 70 bar and a reactor temperature of from 20° C. to 150° C. to form an ethylene alpha-olefin copolymer. The resulting ethylene alpha-olefin copolymer may have a density D of 0.927 g/cc or less, a melt index (I2) of from 0.1 to 100 dg/min, a MWD of from 1.5 to 5.0. The resulting ethylene alpha-olefin copolymer may also have a peak melting temperature Tmax second melt satisfying the following relation: Tmax second melt>D*398?245.
    Type: Application
    Filed: June 7, 2007
    Publication date: February 21, 2008
    Applicant: UNIVATION TECHNOLOGIES, LLC
    Inventors: Rainer Kolb, Agaplos Agapiou, James Farley, Eric Markel, Bruce Savatsky, Christopher Davey, Richard Pannell
  • Publication number: 20070073010
    Abstract: In some embodiments, a method including the steps of monitoring a polymerization reaction which produces a polymer resin in a fluid bed reactor, where a dry melt reference temperature is characteristic of melting behavior of a dry version of the resin, and in response to data indicative of at least one monitored parameter of the reaction, determining a reduced melt reference temperature that is at least substantially equal to the difference between the dry melt reference temperature and a temperature by which the dry melt reference temperature is depressed by the presence of condensable diluent gas with the resin in the reactor. Optionally, the method also includes the step of controlling the reaction in response to the reduced melt reference temperature or a stickiness parameter determined from the reduced melt reference temperature.
    Type: Application
    Filed: November 14, 2006
    Publication date: March 29, 2007
    Inventors: Richard Pannell, Robert Hagerty, Eric Markel
  • Publication number: 20070073012
    Abstract: In some embodiments, a method in which at least one continuity additive (“CA”) and a seed bed are pre-loaded into a reactor, and a polymerization reaction is optionally then performed in the reactor. In other embodiments, at least one flow improver, at least one CA, and a seed bed are pre-loaded into a reactor. Pre-loading of a reactor with a CA can significantly improve continuity of a subsequent polymerization reaction in the reactor during its initial stages, including by reducing sheeting and fouling. The CA can be pre-loaded in dry form (e.g., as a powder), or in liquid or slurry form (e.g., as an oil slurry). To aid delivery of a dry CA to the reactor and combination of the dry CA with a seed bed in the reactor, the dry CA can be combined with a flow improver and the combination of CA and flow improver then loaded into the reactor.
    Type: Application
    Filed: September 28, 2005
    Publication date: March 29, 2007
    Inventors: Richard Pannell, Agapios Agapiou, Eric Markel
  • Publication number: 20060228697
    Abstract: The present invention features methods for producing HCV replicons using HCV encoding sequences from different isolates. The featured methods are based on the discovered importance of NS3 amino acid position 470 in conferring cell culture replication activity to different HCV isolates.
    Type: Application
    Filed: February 9, 2004
    Publication date: October 12, 2006
    Inventors: Jay Grobler, Osvaldo Flores, Eric Markel